Results 111 to 120 of about 7,009,349 (302)
Griselimycin, a cyclic depsidecapeptide produced by Streptomyces griseus, is a promising lead inhibitor of the sliding clamp component of bacterial DNA polymerases (β-subunit of Escherichia coli DNA pol III).
Michael K. Fenwick +32 more
doaj +1 more source
Unlocking the potential of cell‐permeable nanobodies for intracellular applications
This review outlines current strategies for delivery of nanobodies into cells and highlights recent examples of functional applications. By addressing and manipulating intracellular targets, these molecules hold great potential for treating cancer, respiratory diseases and neurological disorders, making this a vibrant area of research in the biomedical
Mariona Gené‐Verdés +2 more
wiley +1 more source
The role of miR‐335‐5p in the redifferentiation of BRAF p.V600E thyroid cancers
The BRAF p.V600E mutation promotes thyroid cancer dedifferentiation and radioiodine resistance. Using a network approach, we identified miR‐335‐5p as a key regulator of BRAF‐mutated thyroid tumors. Restoring miR‐335‐5p increased thyroid‐specific gene expression and iodine uptake in cells and organoids.
Valeria Pecce +11 more
wiley +1 more source
Tianyan Chen,1,* Yawen Liu,2,* Yuan Liu,1 Nannan Hu,1 Yan Dai,1 Chuanlong Zhu,1 Yaping Han,1 Ke Jin,1 Jun Li1 1Department of Infectious Disease, the First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, People’s ...
Chen T +8 more
doaj
Tumour–host interactions in Drosophila: mechanisms in the tumour micro‐ and macroenvironment
This review examines how tumour–host crosstalk takes place at multiple levels of biological organisation, from local cell competition and immune crosstalk to organism‐wide metabolic and physiological collapse. Here, we integrate findings from Drosophila melanogaster studies that reveal conserved mechanisms through which tumours hijack host systems to ...
José Teles‐Reis, Tor Erik Rusten
wiley +1 more source
Wei-Lun Chuang,1,2,* Fu-Chieh Chang,2,3,* Chien-Feng Kuo,1,2 Chih-Chen Lin1,2 1Department of Infectious Diseases, MacKay Memorial Hospital, Taipei City, Taiwan; 2Infection Control Center, MacKay Memorial Hospital, Taipei City, Taiwan ...
Chuang WL, Chang FC, Kuo CF, Lin CC
doaj
Hijacking emergency granulopoiesis: Neutrophil ontogeny and reprogramming in cancer
Neutrophils are highly plastic innate immune cells; their functions in cancer extend beyond the tumour microenvironment. This Review summarises current understanding of neutrophil maturation and heterogeneity and highlights tumour‐induced granulopoiesis as a systemic programme that expands immature, immunosuppressive neutrophils via tumour‐derived ...
Gabriela Marinescu, Yi Feng
wiley +1 more source
Artificial Intelligence in Infectious Disease Diagnostic Technologies
Artificial intelligence (AI), as an emerging interdisciplinary field dedicated to simulating and extending human intelligence, is increasingly integrating into the domain of infectious disease medicine with unprecedented depth and breadth. This narrative
Fei Yu +5 more
core +1 more source
RNA profiling of circulating extracellular vesicles (EVs) from blood samples of men undergoing prostate biopsy identifies transcripts associated with clinically significant prostate cancer. Integrative analysis with public tumor datasets links EV‐derived gene signatures to tumor stage and progression‐free survival, highlighting CASP3, XRCC2, and RIT1 ...
Stefan Werner +14 more
wiley +1 more source
1999年4月1日から施行された感染症の予防及び感染症の患者に対する医療に関する法律においては,これまでは全く異なった1類感染症, 2類感染症, 3類感染症, 4類感染症,指定感染症及び新感染症からなる感染症類型が設けられている.指定感染症は,旧法である伝染病予防法においても規定されていた事項であるが,感染症新法では,適応に当たっての手続保障の厳格化等を講じている.本稿では,指定感染症と新感染症の相違点を中心に感染症類型を概説する.
openaire +2 more sources

